Cargando…

SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma

Background: Recent studies have demonstrated that creatine can promote tumor metastasis and has implications for immune cell function. SLC6A8 encodes a membrane protein that can transport creatine inside and outside the cell. However, there are currently no studies of SLC6A8 in lung adenocarcinoma (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Yongfei, Zhou, Yong, Lou, Ming, Gao, Zhaojia, Li, Xinwei, Yuan, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185669/ https://www.ncbi.nlm.nih.gov/pubmed/35692837 http://dx.doi.org/10.3389/fgene.2022.845373

Ejemplares similares

Long Non-Coding RNA AL513318.2 as ceRNA Binding to hsa-miR-26a-5p Upregulates SLC6A8 Expression and Predicts Poor Prognosis in Non-Small Lung Cancer
por: Fan, Yongfei, et al.
Publicado: (2022)

Corrigendum: Long Non-Coding RNA AL513318.2 as ceRNA Binding to hsa-miR-26a-5p Upregulates SLC6A8 Expression and Predicts Poor Prognosis in Non-Small Lung Cancer
por: Fan, Yongfei, et al.
Publicado: (2022)

CHSY3 can be a Poor Prognostic Biomarker and Mediates Immune Evasion in Stomach Adenocarcinoma
por: Li, Xinwei, et al.
Publicado: (2022)

SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma
por: Huang, Hui, et al.
Publicado: (2021)

Gene expression and prognosis of x-ray repair cross-complementing family members in non-small cell lung cancer
por: Fan, Yongfei, et al.
Publicado: (2021)

Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma
por: Lu, Guojun, et al.
Publicado: (2021)

Low expression of INMT is associated with poor prognosis but favorable immunotherapy response in lung adenocarcinoma
por: Zhou, Xincheng, et al.
Publicado: (2022)

MDFI is a novel biomarker for poor prognosis in LUAD
por: Chen, Pengyu, et al.
Publicado: (2022)

Construction of an immune-related lncRNA pairs model to predict prognosis and immune landscape of lung adenocarcinoma patients
por: Liu, Junhui, et al.
Publicado: (2021)

Mitochondrial Homeostasis–Related lncRNAs are Potential Biomarkers for Predicting Prognosis and Immune Response in Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2022)

Genomics and Prognosis Analysis of N(6)-Methyladenosine Regulators in Lung Adenocarcinoma
por: Ma, Yanpin, et al.
Publicado: (2021)

Single-cell RNA sequencing analysis to explore immune cell heterogeneity and novel biomarkers for the prognosis of lung adenocarcinoma
por: Xu, Yong, et al.
Publicado: (2022)

High expression of KNL1 in prostate adenocarcinoma is associated with poor prognosis and immune infiltration
por: Zhang, Yetao, et al.
Publicado: (2023)

Pan-Cancer Analysis of the Oncogenic and Immunological Role of Solute Carrier Family 6 Member 8 (SLC6A8)
por: Yang, Xin, et al.
Publicado: (2022)

Positive regulators of T cell proliferation as biomarkers for predicting prognosis and characterizing the immune landscape in lung adenocarcinoma
por: Li, Yang, et al.
Publicado: (2022)

The overexpression of GPX8 is correlated with poor prognosis in GBM patients
por: Li, Sibo, et al.
Publicado: (2022)

m(6)A Regulator-Mediated Methylation Modification Patterns and Characterisation of Tumour Microenvironment Infiltration in Non-Small Cell Lung Cancer
por: Fan, Yongfei, et al.
Publicado: (2022)

High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration
por: Wang, Jieyan, et al.
Publicado: (2023)

Aberrant expression of SPAG6 and NM23 predicts poor prognosis of human osteosarcoma
por: Bao, Zhengqi, et al.
Publicado: (2022)

Cell death-related biomarker SLC2A1 has a significant role in prognosis prediction and immunotherapy efficacy evaluation in pan-cancer
por: Wang, Yuhang, et al.
Publicado: (2023)

m(6)A RNA Methylation Regulators Act as Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Wang, Hongbo, et al.
Publicado: (2021)

Identification and Validation of Two Lung Adenocarcinoma-Development Characteristic Gene Sets for Diagnosing Lung Adenocarcinoma and Predicting Prognosis
por: Liu, Cheng, et al.
Publicado: (2020)

Identification of Fatty Acid Metabolism-Related lncRNAs as Biomarkers for Clinical Prognosis and Immunotherapy Response in Patients With Lung Adenocarcinoma
por: Wang, Helin, et al.
Publicado: (2022)

Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer
por: Tian, Yubin, et al.
Publicado: (2022)

Identification of Extracellular Matrix Signatures as Novel Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Zeng, Zhen, et al.
Publicado: (2022)

Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma
por: Li, Feng, et al.
Publicado: (2022)

PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer
por: Li, Xinwei, et al.
Publicado: (2022)

Investigating CENPW as a Novel Biomarker Correlated With the Development and Poor Prognosis of Breast Carcinoma
por: Wang, Luyang, et al.
Publicado: (2022)

Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma
por: Lv, Yanju, et al.
Publicado: (2022)

Vasculogenic mimicry score identifies the prognosis and immune landscape of lung adenocarcinoma
por: Yang, Weichang, et al.
Publicado: (2023)

Tetrasomy 8 Associated with a Poor Prognosis in Acute Monoblastic Leukemia: A Case Report
por: Farag, Fady, et al.
Publicado: (2019)

Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential
por: Fan, Yongfei, et al.
Publicado: (2022)

Polymorphisms in Manganese Transporters SLC30A10 and SLC39A8 Are Associated With Children's Neurodevelopment by Influencing Manganese Homeostasis
por: Wahlberg, Karin E., et al.
Publicado: (2018)

Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma
por: Zhao, Jianhui, et al.
Publicado: (2021)

TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC
por: Lou, Ming, et al.
Publicado: (2020)

Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma
por: Niu, Cong, et al.
Publicado: (2022)

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
por: Tu, Zhengliang, et al.
Publicado: (2021)

TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma
por: Gao, Wen, et al.
Publicado: (2022)

Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma
por: Pan, Shize, et al.
Publicado: (2022)

Overexpression of major CDKN3 transcripts is associated with poor survival in lung adenocarcinoma
por: Fan, Chao, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vpkflltvdlprngsc39jutu3r23